HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Paul Briand Selected Research

CBD1 peptide

6/2006HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Paul Briand Research Topics

Disease

7Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016 - 06/2007
6Neoplasms (Cancer)
12/2012 - 01/2004
4Autoimmune Diseases (Autoimmune Disease)
07/2014 - 01/2010
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2011 - 03/2003
3Infections
09/2008 - 11/2004
2Inflammation (Inflammations)
01/2016 - 09/2012
2Melanoma (Melanoma, Malignant)
06/2010 - 02/2004
2Proteinuria
06/2007 - 02/2003
2Experimental Arthritis
01/2007 - 10/2005
2Virus Diseases (Viral Diseases)
11/2004 - 11/2003
1Lupus Nephritis
01/2016
1Breast Neoplasms (Breast Cancer)
06/2010
1Carcinogenesis
06/2010
1Colonic Neoplasms (Colon Cancer)
02/2010
1Hypersensitivity (Allergy)
06/2007
1Malaria
11/2006
1Ischemia
01/2006
1Rheumatoid Arthritis
10/2005
1Acquired Immunodeficiency Syndrome (AIDS)
11/2004
1Vitiligo
02/2004
1Sialadenitis
03/2003
1Abscess
12/2002
1Communicable Diseases (Infectious Diseases)
12/2002
1HIV Infections (HIV Infection)
06/2002

Drug/Important Bio-Agent (IBA)

10Peptides (Polypeptides)IBA
01/2016 - 06/2002
4AutoantibodiesIBA
01/2016 - 03/2003
4Histones (Histone)IBA
01/2016 - 06/2007
4NucleolinIBA
12/2012 - 06/2002
4VaccinesIBA
09/2008 - 12/2002
3AutoantigensIBA
12/2009 - 07/2005
3ProinsulinIBA
02/2009 - 03/2003
3AntibodiesIBA
09/2008 - 11/2004
2LigandsIBA
12/2012 - 06/2010
2Nucleosomes (Nucleosome)IBA
04/2010 - 12/2009
2DNA (Deoxyribonucleic Acid)IBA
04/2010 - 02/2003
2Collagen Type II (Type II Collagen)IBA
01/2007 - 10/2005
2Glycoproteins (Glycoprotein)IBA
06/2006 - 11/2004
2Caveolin 1IBA
06/2006 - 11/2004
2Amino AcidsFDA Link
11/2003 - 06/2002
1Lysine (L-Lysine)FDA Link
01/2016
1ChromatinIBA
01/2016
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
07/2014
1Pharmaceutical PreparationsIBA
12/2012
1NucleoproteinsIBA
12/2012
1NucleophosminIBA
12/2012
1Tissue Inhibitor of MetalloproteinasesIBA
12/2012
1spliceosomal peptide P140IBA
09/2012
1Insulin (Novolin)FDA Link
12/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2010
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
06/2010
1ResveratrolIBA
02/2010
1preproinsulinIBA
02/2009
1HLA-A*02:01 antigenIBA
02/2009
1EpitopesIBA
02/2009
1Complement Receptors (Complement Receptor)IBA
09/2008
1Complement System Proteins (Complement)IBA
09/2008
1Peptide Elongation Factor Tu (EF-Tu)IBA
09/2008
1Immunoglobulin G (IgG)IBA
06/2007
1Galactose (Galactopyranose)FDA LinkGeneric
01/2007
1Immunodominant EpitopesIBA
01/2007
1DipeptidesIBA
11/2006
1Biological ProductsIBA
11/2006
1Immune Sera (Antisera)IBA
06/2006
1CBD1 peptideIBA
06/2006
11- palmitoyl- 2- (10- (4- ((trifluoromethyl)diazirinyl)phenyl)- 8- oxadecanoyl)- sn- glycero- 3- phosphocholineIBA
01/2006
1HydroxylysineIBA
10/2005
1GlycopeptidesIBA
10/2005
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
11/2004
1Neoplasm Antigens (Tumor Antigens)IBA
02/2004
1MetallothioneinIBA
02/2004
1LactoferrinIBA
01/2004
1Proteins (Proteins, Gene)FDA Link
11/2003
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
03/2003

Therapy/Procedure

4Therapeutics
06/2010 - 02/2004
1Intravenous Administration
02/2003